Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer
  2. Senchenko, V. N.; Anedchenko, E. A.; Kondratieva, T. T.; Krasnov, G. S.; Dmitriev, A. A.; Zabarovska, V. I.; Pavlova, T. V.; Kashuba, V. I.; Lerman, M. I.; Zabarovsky, E. R.
  3. Bmc Cancer. 2010, Mar; 10: 13.
  1. 2.   HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro
  2. Wang, F. L.; Grigorieva, E. V.; Li, J. F.; Senchenko, V. N.; Pavlova, T. V.; Anedchenko, E. A.; Kudryavtseva, A. V.; Tsimanis, A.; Angeloni, D.; Lerman, M. I.; Kashuba, V. I.; Klein, G.; Zabarovsky, E. R.
  3. Plos One. 2008, Aug; 3(8): 8.
  1. 3.   Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours
  2. Ivanova, A. V.; Vortmeyer, A.; Ivanov, S. V.; Nickerson, M. L.; Maher, E. R.; Lerman, M. I.
  3. Journal of Pathology. 2008 214(1): 46-57.
  1. 4.   Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage
  2. Lo, P. H. Y.; Xie, D.; Chan, K. C.; Xu, F. P.; Kuzmin, I.; Lerman, M. I.; Law, S.; Chua, D.; Sham, J.; Lung, M. L.
  3. Cancer Letters. 2007, Nov; 257(2): 199-205.
  1. 5.   Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma
  2. Yau, W. L.; Lung, H. L.; Zabarovsky, E. R.; Lerman, M. I.; Sham, J. S. T.; Chua, D. T. T.; Tsao, S. W.; Stanbridge, E. J.; Lung, M. L.
  3. International Journal of Cancer. 2006, Dec; 119(12): 2821-2826.
  1. 6.   Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C
  2. Li, F.; Wang, F.; Haraldson, K.; Protopopov, A.; Duh, F. M.; Geil, L.; Kuzmin, I.; Minna, J. D.; Stanbridge, E.; Braga, E.; Kashuba, V. I.; Klein, G.; Lerman, M. I.; Zabarovsky, E. R.
  3. Cancer Research. 2004, SEP 15; 64(18): 6438-6443.
  1. 7.   Differential B cell expression of mouse Fc receptor homologs
  2. Davis, R. S.; Stephan, R. P.; Chen, C. C.; Dennis, G.; Cooper, M. D.
  3. International Immunology. 2004, SEP; 16(9): 1343-1353.
  1. 8.   Animal model - Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene
  2. Ivanov, S. V.; Ward, J. M.; Tessarollo, L.; McAreavey, D.; Sachdev, V.; Fananapazir, L.; Banks, M. K.; Morris, N.; Djurickovic, D.; vor-Henneman, D. E.; Wei, M. H.; Alvord, G. W.; Gao, B. N.; Richardson, J. A.; Minna, J. D.; Rogawski, M. A.; Lerman, M. I.
  3. American Journal of Pathology. 2004, SEP; 165(3): 1007-1018.
  1. 9.   Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location
  2. Maranchie, J. K.; Afonso, A.; Albert, P. S.; Kalyandrug, S.; Phillips, J. L.; Zhou, S.; Peterson, J.; Ghadimi, B. M.; Hurley, K.; Riss, J.; Vasselli, J. R.; Ried, T.; Zbar, B.; Choyke, P.; Walther, M. M.; Klausner, R. D.; Linehan, W. M.
  3. Human Mutation. 2004 23(1): 40-46.
  1. 10.   Characterization of a new SNP c767A/T (Arg222Trp) in the candidate TSG FUS2 on human chromosome 3p21.3: prevalence in Asian populations and analysis of association with nasopharyngeal cancer
  2. Duh, F. M.; Fivash, M.; Moody, M.; Lung, M. L.; Guo, X.; Stanbridge, E.; Dean, M.; Voevoda, M.; Hu, L. F.; Kashuba, V.; Zabarovsky, E. R.; Qian, C. N.; Godbole, S.; Teh, B. T.; Lerman, M. I.
  3. Molecular and Cellular Probes. 2004 18(1): 39-44.
  1. 11.   RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies
  2. Kashuba, V. I.; Li, J. F.; Wang, F. L.; Senchenko, V. N.; Protopopov, A.; Malyukova, A.; Kutsenko, A. S.; Kadyrova, E.; Zabarovska, V. I.; Muravenko, O. V.; Zelenin, A. V.; Kisselev, L. L.; Kuzmin, I.; Minna, J. D.; Winberg, G.; Ernberg, I.; Braga, E.; Lerman, M. I.; Klein, G.; Zabarovsky, E. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(14): 4906-4911.
  1. 12.   Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection
  2. Kuzmin, I.; Liu, L. M.; Dammann, R.; Geil, L.; Stanbridge, E. J.; Wilczynski, S. P.; Lerman, M. I.; Pfeifer, G. P.
  3. Cancer Research. 2003 63(8): 1888-1893.
  1. 13.   Epigenetic inactivation of RASSF1A in head and neck cancer
  2. Dong, S. M.; Sun, D. I.; Benoit, N. E.; Kuzmin, I.; Lerman, M. I.; Sidransky, D.
  3. Clinical Cancer Research. 2003 9(10, Part 1): 3635-3640.
  1. 14.   Role of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus Env proteins
  2. Liu, S. L.; Duh, F. M.; Lerman, M. I.; Miller, A. D.
  3. Journal of Virology. 2003 77(5): 2850-2858.
  1. 15.   Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas
  2. Senchenko, V.; Liu, J.; Braga, E.; Mazurenko, N.; Loginov, W.; Seryogin, Y.; Bazov, I.; Protopopov, A.; Kisseljov, F. L.; Kashuba, V.; Lerman, M. I.; Klein, G.; Zabarovsky, E. R.
  3. Oncogene. 2003 22(19): 2984-2992.
  1. 16.   Studying cancer families to identify kidney cancer genes
  2. Zbar, B.; Klausner, R.; Linehan, W. M.
  3. Annual Review of Medicine-Selected Topics in the Clinical Sciences. 2003 54: 217-233.
  1. 17.   Critical tumor-suppressor gene regions on chromosome 3p in major human epithelial malignancies: Allelotyping and quantitative real-time PCR
  2. Braga, E.; Senchenko, V.; Bazov, I.; Loginov, W.; Liu, J.; Ermilova, V.; Kazubskaya, T.; Garkavtseva, R.; Mazurenko, N.; Kisseljov, F.; Lerman, M. I.; Klein, G.; Kisselev, L.; Zabarovsky, E. R.
  3. International Journal of Cancer. 2002 100(5): 534-541.
  1. 18.   The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells
  2. Kuzmin, I.; Gillespie, J. W.; Protopopov, A.; Geil, L.; Dreijerink, K.; Yang, Y. F.; Vocke, C. D.; Duh, F. M.; Zabarovsky, E.; Minna, J. D.; Rhim, J. S.; Emmert-Buck, M. R.; Linehan, W. M.; Lerman, M. I.
  3. Cancer Research. 2002 62(12): 3498-3502.
  1. 19.   Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers
  2. Zabarovsky, E. R.; Lerman, M. I.; Minna, J. D.
  3. Oncogene. 2002 21(45): 6915-6935.
  1. 20.   LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells
  2. Sutherl, L. C.; Lerman, M.; Williams, G. T.; Miller, B. A.
  3. Oncogene. 2001 20(21): 2713-2719.
  1. 21.   Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
  2. Agathanggelou, A.; Honorio, S.; Macartney, D. P.; Martinez, A.; Dallol, A.; Radar, J.; Fullwood, P.; Chauhan, A.; Walker, R.; Shaw, J. A.; Hosoe, S.; Lerman, M. I.; Minna, J. D.; Maher, E. R.; Latif, F.
  3. Oncogene. 2001 20(12): 1509-1518.
  1. 22.   Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression
  2. Burbee, D. G.; Forgacs, E.; Zochbauer-Muller, S.; Shivakumar, L.; Fong, K.; Gao, B. N.; Randle, D.; Kondo, M.; Virmani, A.; Bader, S.; Sekido, Y.; Latif, F.; Milchgrub, S.; Toyooka, S.; Gazdar, A. F.; Lerman, M. I.; Zabarovsky, E.; White, M.; Minna, J. D.
  3. Journal of the National Cancer Institute. 2001 93(9): 691-699.
  1. 23.   Impaired FHIT expression characterizes serous ovarian carcinoma
  2. Ozaki, K.; Enomoto, T.; Yoshino, K.; Fujita, M.; Buzard, G. S.; Kawano, K.; Yamasaki, M.; Murata, Y.
  3. British Journal of Cancer. 2001 85(2): 247-254.
  1. 24.   Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells
  2. Kondo, M.; Ji, L.; Kamibayashi, C.; Tomizawa, Y.; Randle, D.; Sekido, Y.; Yokota, J.; Kashuba, V.; Zabarovsky, E.; Kuzmin, I.; Lerman, M.; Roth, J.; Minna, J. D.
  3. Oncogene. 2001 20(43): 6258-6262.
  1. 25.   Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B
  2. Tomizawa, Y.; Sekido, Y.; Kondo, M.; Gao, B. N.; Yokota, J.; Roche, J.; Drabkin, H.; Lerman, M. I.; Gazdar, A. F.; Minna, J. D.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(24): 13954-13959.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel